Key result
Second-generation cryoballoon ablation resulted in a similar rate of atrial tachyarrhythmia recurrence compared to radiofrequency ablation in patients with atrial fibrillation.
Why the study?
Does second-generation cryoballoon ablation reduce recurrence of atrial tachyarrhythmia compared to radiofrequency ablation in patients with atrial fibrillation?
Systematic Review (n=4,228)
Does second-generation cryoballoon ablation reduce recurrence of atrial tachyarrhythmia compared to radiofrequency ablation in patients with atrial fibrillation?
Answers are grounded in this paper and cite their sources.
Second-generation cryoballoon ablation has comparable efficacy to radiofrequency ablation for atrial fibrillation, with shorter procedure times and fewer serious complications, though it carries a higher risk of transient phrenic nerve injury.
The cryoballoon was invented to achieve circumferential pulmonary vein isolation more efficiently to compliment the shortcomings of point-by-point ablation by radiofrequency ablation (RFA). Its efficacy and safety were shown to be comparable to those of RFA, and the clinical outcomes have improved with the second-generation cryoballoon. The basic biophysics, implemental techniques, procedural recommendations, clinical outcomes, and complications of the cryoballoon are presented in this practical and systematic review.
No takes yet. Share an insight, caveat, or question.
Jin et al. (2017) conducted a systematic review in Atrial fibrillation (n=4,228). Second-generation cryoballoon ablation (CB-2) vs. Radiofrequency ablation (RFA) was evaluated on Recurrence of atrial tachyarrhythmia (ATA) during follow-up (OR 0.81, 95% CI 0.62-1.05, p=0.11). Second-generation cryoballoon ablation resulted in a similar rate of atrial tachyarrhythmia recurrence compared to radiofrequency ablation in patients with atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: